Flibanserin

How to Increase Sexual Desire After a Partial Hysterectomy

By NWHN Staff | Sep 18, 2019 | Comments Off on How to Increase Sexual Desire After a Partial Hysterectomy

If you are experiencing low sexual desire, some alternative methods may work better without Addyi’s harmful side effects.

The NWHN’s Statement on the FDA Ordering Sprout Pharmaceuticals to Retain Black Box Label Warning Women Not Mix Addyi and Alcohol

By Cindy Pearson | Apr 12, 2019 | Comments Off on The NWHN’s Statement on the FDA Ordering Sprout Pharmaceuticals to Retain Black Box Label Warning Women Not Mix Addyi and Alcohol

FOR IMMEDIATE RELEASE Contact: Evita Almassi, ealmassi@nwhn.org
or (202) 682-6240

The NWHN Advises Women to Be Cautious About Using Flibanserin Until New Studies Are Fully Vetted

By Cindy Pearson | Mar 26, 2019 | Comments Off on The NWHN Advises Women to Be Cautious About Using Flibanserin Until New Studies Are Fully Vetted

FOR IMMEDIATE RELEASE Contact: Evita Almassi, ealmassi@nwhn.org

Keep Passing on the Pink Pill: DON’T “Get Addyi Now”!

By NWHN Staff | Jan 24, 2019 | Comments Off on Keep Passing on the Pink Pill: DON’T “Get Addyi Now”!

What do you do when your product isn’t popular and sales have slumped? Gin up an advertising campaign to convince consumers that they absolutely have to have what you’re selling.

Addyi Health Fact Sheet

By NWHN Staff | Jul 30, 2018 | Comments Off on Addyi Health Fact Sheet

Flibanserin (brand name: Addyi) is the first drug approved by the U.S. Food and Drug Administration (FDA) to treat lack of sexual desire (Hypoactive Sexual Desire Disorder) in premenopausal women.

How Can I Get an Addyi Prescription if My Insurance Does Not Cover It?

By NWHN Staff | Jun 28, 2018 | Comments Off on How Can I Get an Addyi Prescription if My Insurance Does Not Cover It?

“My doctor prescribed me Addyi for HSDD. I cannot afford it and my insurance does not cover it. Are there any other resources to get this medication?”

Addyi Update

By NWHN Staff | Mar 1, 2018 | Comments Off on Addyi Update

Taken from the March/April 2018 issue of The Women’s Health Activist Newsletter. In 2015, Valeant, a pharmaceutical giant known for price gouging and shady business practices paid $1 billion in cash for a flawed sexual enhancement drug marketed to women…

Menopause and Sexuality

By NWHN Staff | Sep 9, 2016 | Comments Off on Menopause and Sexuality

Popular culture tells us that many women lose interest in sex during or after menopausal transition, but those ageist and sexist messages aren’t supported by good scientific research. We want you to have the facts and offer a few helpful remedies.

Health Advocates Issue One-Year Report Card on Addyi, the Female Libido Drug

By Shaniqua Seth | Aug 18, 2016 | Comments Off on Health Advocates Issue One-Year Report Card on Addyi, the Female Libido Drug

FOR IMMEDIATE RELEASE
Contact: Shaniqua Seth at sseth@nwhn.org or 202.682-2640, ext. 225

Addyi 1 Year Later: What’s the Score?

By NWHN Staff | Aug 18, 2016 | Comments Off on Addyi 1 Year Later: What’s the Score?

Click image to download PDF of the report card. Report Card References 1 – Addyi’s FDA Warning Addyi’s life-threatening side effects were so grave that they warranted the strictest possible warning by the FDA—a “black box warning.” Those side effects…